CN Patent

CN102153515B — N,N′-双取代脲类Raf激酶抑制剂及其制备方法和用途

Assigned to Shenzhen Aomei Pharmaceutical Technology Development Co Ltd · Expires 2013-02-27 · 13y expired

What this patent protects

本发明涉及药物化学领域，具体涉及一种N，N′-双取代脲类化合物、它们的制备方法、含有这些化合物的药用组合物以及它们的医疗用途，特别是作为Raf激酶抑制剂的用途。

USPTO Abstract

本发明涉及药物化学领域，具体涉及一种N，N′-双取代脲类化合物、它们的制备方法、含有这些化合物的药用组合物以及它们的医疗用途，特别是作为Raf激酶抑制剂的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN102153515B
Jurisdiction
CN
Classification
—
Expires
2013-02-27
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Aomei Pharmaceutical Technology Development Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.